日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen

表达半胱氨酸蛋白酶的非致病性重组利什曼原虫与白蛉唾液抗原联合使用,可增强其保护效力

Zahedifard, Farnaz; Gholami, Elham; Taheri, Tahereh; Taslimi, Yasaman; Doustdari, Fatemeh; Seyed, Negar; Torkashvand, Fatemeh; Meneses, Claudio; Papadopoulou, Barbara; Kamhawi, Shaden; Valenzuela, Jesus G; Rafati, Sima

Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis

基于三基因融合重组塔兰托利什曼原虫疫苗的新型初免-加强免疫策略在小鼠实验性内脏利什曼病中的应用

Saljoughian, Noushin; Taheri, Tahereh; Zahedifard, Farnaz; Taslimi, Yasaman; Doustdari, Fatemeh; Bolhassani, Azam; Doroud, Delaram; Azizi, Hiva; Heidari, Kazem; Vasei, Mohammad; Namvar Asl, Nabiollah; Papadopoulou, Barbara; Rafati, Sima

Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidate

人类中性粒细胞肽-1(HNP-1):一种新的抗利什曼病候选药物

Sara Dabirian, Yasaman Taslimi, Farnaz Zahedifard, Elham Gholami, Fatemeh Doustdari, Mahdieh Motamedirad, Shohreh Khatami, Kayhan Azadmanesh, Susanne Nylen, Sima Rafati

In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response

对六种已知的利什曼原虫抗原进行计算机分析,并对引发 HLA-A2 限制性 CD8 T 细胞反应的特定表位进行体外评估

Negar Seyed, Farnaz Zahedifard, Shima Safaiyan, Elham Gholami, Fatemeh Doustdari, Kayhan Azadmanesh, Maryam Mirzaei, Nasir Saeedi Eslami, Akbar Khadem Sadegh, Ali Eslami Far, Iraj Sharifi, Sima Rafati